Skip to main content

Greater Bay Area — Cross-Border Device Supply

HK-unique · GBA pilot · Cross-border healthcare

What Is the GBA Initiative?​

The Guangdong–Hong Kong–Macao Greater Bay Area (GBA) is a Chinese national initiative linking Hong Kong, Macao, and nine Guangdong cities into an integrated economic and innovation zone. Within the GBA, a specific cross-border medical device pilot programme allows:

  • MDACS-listed devices to be used in designated GBA hospitals in Guangdong
  • Devices to cross the border for use in specific clinical settings without full NMPA (China) registration

This is a significant HK-unique pathway with no parallel in any other RAPath jurisdiction.

How the Pilot Works​

Under the GBA pilot:

  1. A device must hold a valid MDACS listing (HKMD number) in Hong Kong
  2. The Guangdong provincial health authority designates hospitals eligible to participate
  3. Designated hospitals may access MDACS-listed devices for clinical use, leveraging the HK regulatory approval as the reference
  4. Full NMPA registration in China is not required for this specific pilot use

Strategic Implications​

For manufacturers seeking China market access:

  • An MDACS listing can serve as an entry point into GBA clinical use ahead of full NMPA registration
  • GBA clinical experience and outcomes data may be useful in supporting a subsequent NMPA registration application
  • The GBA pilot is currently limited in scope — it does not substitute for NMPA registration for national China market access

Current Status​

The GBA cross-border device pilot is an evolving programme. Check with the Hong Kong Medical Device Division (MDD) and the Guangdong Provincial Medical Products Administration for the current list of designated hospitals, eligible device categories, and application process.

Seek expert guidance

GBA cross-border supply involves both Hong Kong and Mainland China regulatory requirements. Engage a regulatory affairs professional with expertise in both MDACS and NMPA frameworks.